SCHEMBL5500774

SCHEMBL5500774

O=C1Cc2cnnnc2N1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.41
CHEK1 O14757 1/20 0.41
AURKA O14965 1/20 0.41
DAPK3 O43293 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
ABL1 P00519 1/20 0.41
NTRK1 P04629 1/20 0.41
CSF1R P07333 1/20 0.41
RET P07949 1/20 0.41
MET P08581 1/20 0.41
PDGFRB P09619 1/20 0.41
PIM1 P11309 1/20 0.41
FGFR1 P11362 1/20 0.41
PDGFRA P16234 1/20 0.41
FLT1 P17948 1/20 0.41
LTK P29376 1/20 0.41
GRK5 P34947 1/20 0.41
MAP2K2 P36507 1/20 0.41
FLT3 P36888 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5501537 0.72 AURKA (0.41) KDRCHEK1AURKADAPK3PRKD3
SCHEMBL5503921 0.68 AHR (0.35) PDE3BPDE3AAHRPDK2CMA1
SCHEMBL322055 0.68 CHEK1 (0.49) KDRCHEK1AURKADAPK3PRKD3
SCHEMBL661744 0.65 KDR (0.42) KDRCHEK1AURKADAPK3PRKD3
SCHEMBL19152820 0.65 AHR (0.37) KDRCHEK1AURKADAPK3PRKD3
SCHEMBL4044760 0.65 PDE3B (0.48) KDRCHEK1AURKADAPK3PRKD3
SCHEMBL6903182 0.65 GSK3A (0.40) GSK3AGSK3B
SCHEMBL18238728 0.63 PDE3B (0.42) KDRCHEK1AURKADAPK3PRKD3
SCHEMBL30920905 0.63 NPC1 (0.46) AURKAGSK3AGSK3BCDK5AURKB
SCHEMBL22641044 0.63 CHEK1 (0.40) KDRCHEK1AURKADAPK3PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1005470-B1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ASTRAZENECA AB (SE) 2007-08-01 EP disclosed
US-6294532-B1 TREATMENT OF A NUMBER OF DISEASE STATES INCLUDING CANCER AND RHEUMATOID ARTHRITIS. ZENECA LIMITED (GB) 2001-09-25 US disclosed
EP-1005470-A1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ZENECA LIMITED (GB) 2000-06-07 EP disclosed
WO-1999010349-A1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ZENECA LIMITED (GB) 1999-03-04 WO disclosed